Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality

Aim: Evaluation of a breast cancer (BC) screening programme is necessary to ensure its quality. Performance measurements might be prioritized considering the association with outcomes related to BC mortality. We piloted an approach to explore the association of selected performance measurements with...

Descripción completa

Detalles Bibliográficos
Autores: Canelo-Aybar, C, Alonso-Coello, P, Muratov, S, Tarride, JE, Dimitrova, N, Giusti, F, Borisch, B, Castells, X, Duffy, SW, Fitzpatrick, P, Follmann, M, Giordano, L, Hofvind, S, Lebeau, A, Quinn, C, Torresin, A, Rossi, PG, Schünemann, H, Nyström, L, Broeders, M
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p20452
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20452
Access Level:acceso abierto
Palabra clave:Breast Neoplasms/diagnostic imaging*
Early detection of Cancer*/methods
Female
Mass screening/methods
Program evaluation
Quality indicators, health care/standards
id ES_97f4bef2efe0cc0669f6970cbd6fdc0c
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p20452
network_acronym_str ES
network_name_str España
repository_id_str
spelling Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortalityCanelo-Aybar, CAlonso-Coello, PMuratov, STarride, JEDimitrova, NGiusti, FBorisch, BCastells, XDuffy, SWFitzpatrick, PFollmann, MGiordano, LHofvind, SLebeau, AQuinn, CTorresin, ARossi, PGSchünemann, HNyström, LBroeders, MBreast Neoplasms/diagnostic imaging*Early detection of Cancer*/methodsFemaleMass screening/methodsProgram evaluationQuality indicators, health care/standardsAim: Evaluation of a breast cancer (BC) screening programme is necessary to ensure its quality. Performance measurements might be prioritized considering the association with outcomes related to BC mortality. We piloted an approach to explore the association of selected performance measurements with incidence-based BC mortality (IBM). Methods: We performed an ecological analysis of aggregated data from regional or national population-based cancer registries and BC screening programmes in Europe, using 13 performance indicators. We built a panel data (longitudinal cross-sectional) regression model to estimate the association between screening performance measurements and IBM rates. Results: We included data of 9 programmes and registries from Italy, Spain, Norway, Ireland and the Czech Republic. The number of screening years included in the dataset ranged from 5 to 20 years. In adjusted panel analyses, higher screening coverage, breast cancer detection rates (BCDR prevalent and subsequent rounds), node-negative proportion, and episode sensitivity were associated with lower incidence-based mortality (IBM), whereas a higher interval cancer rate was associated with higher IBM. The association for recall rate in subse-quent examinations was small and imprecise. Conclusion: Our pilot approach suggests association of several performance indicators with IBM. These indicators were related to the implementation of the screening programme (screening coverage), sensitivity (BC detection rate), and efficiency (recall rate). Further studies with larger datasets and individual data may confirm these findings.CHURCHILL LIVINGSTONE2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20452BREASTISSN: 09609776ISSNe: 15323080reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p204522026-06-14T12:41:47Z
dc.title.none.fl_str_mv Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
title Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
spellingShingle Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
Canelo-Aybar, C
Breast Neoplasms/diagnostic imaging*
Early detection of Cancer*/methods
Female
Mass screening/methods
Program evaluation
Quality indicators, health care/standards
title_short Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
title_full Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
title_fullStr Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
title_full_unstemmed Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
title_sort Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
dc.creator.none.fl_str_mv Canelo-Aybar, C
Alonso-Coello, P
Muratov, S
Tarride, JE
Dimitrova, N
Giusti, F
Borisch, B
Castells, X
Duffy, SW
Fitzpatrick, P
Follmann, M
Giordano, L
Hofvind, S
Lebeau, A
Quinn, C
Torresin, A
Rossi, PG
Schünemann, H
Nyström, L
Broeders, M
author Canelo-Aybar, C
author_facet Canelo-Aybar, C
Alonso-Coello, P
Muratov, S
Tarride, JE
Dimitrova, N
Giusti, F
Borisch, B
Castells, X
Duffy, SW
Fitzpatrick, P
Follmann, M
Giordano, L
Hofvind, S
Lebeau, A
Quinn, C
Torresin, A
Rossi, PG
Schünemann, H
Nyström, L
Broeders, M
author_role author
author2 Alonso-Coello, P
Muratov, S
Tarride, JE
Dimitrova, N
Giusti, F
Borisch, B
Castells, X
Duffy, SW
Fitzpatrick, P
Follmann, M
Giordano, L
Hofvind, S
Lebeau, A
Quinn, C
Torresin, A
Rossi, PG
Schünemann, H
Nyström, L
Broeders, M
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Breast Neoplasms/diagnostic imaging*
Early detection of Cancer*/methods
Female
Mass screening/methods
Program evaluation
Quality indicators, health care/standards
topic Breast Neoplasms/diagnostic imaging*
Early detection of Cancer*/methods
Female
Mass screening/methods
Program evaluation
Quality indicators, health care/standards
description Aim: Evaluation of a breast cancer (BC) screening programme is necessary to ensure its quality. Performance measurements might be prioritized considering the association with outcomes related to BC mortality. We piloted an approach to explore the association of selected performance measurements with incidence-based BC mortality (IBM). Methods: We performed an ecological analysis of aggregated data from regional or national population-based cancer registries and BC screening programmes in Europe, using 13 performance indicators. We built a panel data (longitudinal cross-sectional) regression model to estimate the association between screening performance measurements and IBM rates. Results: We included data of 9 programmes and registries from Italy, Spain, Norway, Ireland and the Czech Republic. The number of screening years included in the dataset ranged from 5 to 20 years. In adjusted panel analyses, higher screening coverage, breast cancer detection rates (BCDR prevalent and subsequent rounds), node-negative proportion, and episode sensitivity were associated with lower incidence-based mortality (IBM), whereas a higher interval cancer rate was associated with higher IBM. The association for recall rate in subse-quent examinations was small and imprecise. Conclusion: Our pilot approach suggests association of several performance indicators with IBM. These indicators were related to the implementation of the screening programme (screening coverage), sensitivity (BC detection rate), and efficiency (recall rate). Further studies with larger datasets and individual data may confirm these findings.
publishDate 2025
dc.date.none.fl_str_mv 2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20452
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20452
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv CHURCHILL LIVINGSTONE
publisher.none.fl_str_mv CHURCHILL LIVINGSTONE
dc.source.none.fl_str_mv BREAST
ISSN: 09609776
ISSNe: 15323080
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869414138025869312
score 15,811543

Similares en LA Referencia